Results 101 to 110 of about 265,387 (207)

Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines. [PDF]

open access: yesVaccines (Basel), 2021
Albutti A   +9 more
europepmc   +1 more source

A mouse model for direct evaluation of cholera vaccines [PDF]

open access: yes, 2009
Cholera continues to be an important cause of morbidity and mortality in large parts of the developing world and is a significant negative factor for economic development.
Nygren, Erik
core   +1 more source

Cholera in Sub-Saharan Africa: Unveiling neglected drivers and pathways to elimination.

open access: yesPLoS Neglected Tropical Diseases
Cholera is a virulent infectious disease caused by the Gram-negative, comma-shaped bacteria Vibrio cholerae, after ingesting contaminated food and/or water. If left untreated, it can kill within 5 days.
Beenzu Siamalube   +4 more
doaj   +1 more source

Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population

open access: yesVaccines
Despite the successful introduction of oral cholera vaccines, Zambia continues to experience multiple, sporadic, and protracted cholera outbreaks in various parts of the country. While vaccines have been useful in staying the cholera outbreaks, the ideal
Caroline Cleopatra Chisenga   +15 more
doaj   +1 more source

Oral vaccines for preventing cholera

open access: yes, 2011
Background: Cholera is a cause of acute watery diarrhoea which can cause dehydration and death if not adequately treated. It usually occurs in epidemics, and is associated with poverty and poor sanitation.
David Sinclair   +9 more
core   +1 more source

Willingness to pay for oral cholera vaccines in urban Bangladesh. [PDF]

open access: yesPLoS One, 2020
Sarker AR   +11 more
europepmc   +1 more source

Cholera

open access: yes, 2023
Cholera was one of the shock diseases of the world in the nineteenth century and beyond. It was hard to differentiate from other diarrhoeal diseases and so its presence in Tasmania cannot be definietly verified, but a number of cases were reported.
Stefan Petrow (14746672)
core  

Research Bulletin 18, Value of Commercial Vaccines and Bacterins Against Fowl Cholera, 1920

open access: yes, 1920
Research Bulletin 18, Value of Commercial Vaccines and Bacterins Against Fowl Cholera ...

core  

Strategies for achieving a healthy oral cholera vaccine market: Model-enabled scenario exploration of supply and demand dynamics.

open access: yesPLoS Neglected Tropical Diseases
Following decades of progress, recent years have seen a resurgence of cholera. This has led to unprecedented demand for vaccines from the global emergency stockpile of oral cholera vaccines (OCVs), for outbreak and humanitarian use.
Donovan Guttieres   +3 more
doaj   +1 more source

Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions

open access: yesHealth Science Reports
Background and Aim Cholera is a life‐threatening infectious disease that is still one of the most common acute watery diarrheal diseases in the world today.
Abdulrahman K. Ahmed   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy